NCT00288847 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

von Tscharner V, Goepfert B, Nigg BM
Changes in EMG signals for the muscle tibialis anterior while running barefoot or with shoes resolved by non-linearly scaled wavelets. J Biomech. 2003 Aug;36(8):1169-76.
Von Tscharner V, Goepfert B
Estimation of the interplay between groups of fast and slow muscle fibers of the tibialis anterior and gastrocnemius muscle while running. J Electromyogr Kinesiol. 2006 Apr;16(2):188-97. Epub 2005 Sep 1.
von Tscharner V, Goepfert B
Gender dependent EMGs of runners resolved by time/frequency and principal pattern analysis. J Electromyogr Kinesiol. 2003 Jun;13(3):253-72.
von Tscharner V, Göpfert B, Wirz D, Friederich NF
[Analysis of wavelet transformed electromyographic signals that were altered by wearing a knee brace]. Biomed Tech (Berl). 2004 Mar;49(3):43-8. German.
von Tscharner V
Intensity analysis in time-frequency space of surface myoelectric signals by wavelets of specified resolution. J Electromyogr Kinesiol. 2000 Dec;10(6):433-45.
von Tscharner V
Time-frequency and principal-component methods for the analysis of EMGs recorded during a mildly fatiguing exercise on a cycle ergometer. J Electromyogr Kinesiol. 2002 Dec;12(6):479-92.

Functional Surface Electromyogram of Knee Extensors in Healthy Humans and Patients With Patella-dislocation.

Clinical trial NCT00288847 - References